To examine if the different locations of EGFR expression correlated with survival of patients after surgery, Kaplan-Meier analysis was performed comparing EGFR-positive with EGFR-negative tumors in RCC patients. The gene discussed is EGFR; the disease is renal cell adenocarcinoma.